Current Axsome Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
217.31 USD
+0.61 %
Median
218.28 USD
+1.06 %
Max
273.00 USD
Min
151.50 USD
Last Price
215.99 USD
Buy
24
Hold
2
Sell
0
The average target price for Axsome Therapeutics is 217.31 USD. (+0.61 % above the current price)
The median price target of Axsome Therapeutics is 218.28 USD.
Stock analysts from many renowned investment banks are closely examining the Axsome Therapeutics stock. They conclude their professional Axsome Therapeutics stock analyses with a clear recommendation for the Axsome Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 24 | 2 | 0 | 217.31 USD |
| 2026-01-01 | 25 | 1 | 0 | 207.38 USD |
| 2025-12-01 | 25 | 1 | 0 | 182.31 USD |
| 2025-12-01 | 25 | 1 | 0 | 182.31 USD |
| 2025-11-01 | 25 | 1 | 0 | 182.31 USD |
| 2025-11-01 | 25 | 1 | 0 | 180.65 USD |
Axsome Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Axsome Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 974.00 M USD | -125.00 M USD | -2.47 USD |
| 2027e | 1.57 B USD | 281.00 M USD | 5.55 USD |
| 2028e | 2.31 B USD | 739.00 M USD | 14.60 USD |